Lead the way. Molecular Imaging. GE Healthcare. imagination at work

Transcription

1 2010 General Electric Company All rights reserved. General Electric Company reserves the right to make changes in specifications and features shown herein, or discontinue the product described at any time without notice or obligation. GE, GE Monogram, Alcyone, ASiR, Discovery, and SnapShot are trademarks of General Electric Company. GE Healthcare, a division of General Electric Company. GE Healthcare Lead the way. About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services helps our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our healthymagination vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access, and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at Molecular Imaging GE Healthcare 3000 N. Grandview Blvd. Waukesha, WI U.S.A. imagination at work MI EN-us

2 Biomarker Development Regulatory Compliance Workflow Efficiency Tracer Distribution Pre-Clinical Imaging Physician Education Keep ahead of the curve in molecular imaging. Clinical Imaging The future of diagnostic imaging lies in the smallest functional unit of human life. By examining molecular processes and pathways using radio-labeled biomarkers, molecular imaging helps you identify specific pathologies and assess function. Combined with anatomical imaging in PET/CT and SPECT/CT, it helps you localize disease more precisely to make better treatment decisions. Molecular imaging is understanding disease. From the beginning. It aligns perfectly with GE Healthcare s healthymagination commitment to improve healthcare quality, cost, and access everywhere. And it opens up endless exciting clinical and research possibilities. Despite all the challenges of starting or growing your molecular imaging capabilities, at GE we help make molecular imaging easier and more accessible. From drug development to helping you fight disease with advanced imaging for oncology, cardiology, and neurology, we alone offer you the total solution of technology, products, and services to support you along the molecular imaging pathway. We lead the industry with the world s largest installed base of molecular imaging research and clinical equipment, and a long heritage of proven products and results. Collaborating with you, we can help you build the competency, confidence, and expertise to realize your vision of molecular imaging. We make it easier to think big about seeing small.

3 Discover Set a course to what lies ahead. If we can develop techniques where we can detect just a few thousand cells, or even a few hundred thousand cells, we can catch disease much earlier and then change the outcome for the patient and possibly even cure diseases. Sanjiv Sam Gambhir MD, PhD Director, Molecular Imaging Program at Stanford University Understanding disease from the beginning starts in the research lab. Much like the microscope opened new vistas to early scientists, researchers today use GE Healthcare Molecular Imaging technology to develop drugs, assay specific life processes, and unravel complex interactions in pre-clinical and clinical models. Our cutting-edge tools empower researchers to lead their field by developing novel studies in this growing area of diagnostic imaging. With more than 80 years experience in chemistry and radiopharmaceuticals, GE Healthcare is a pioneer in tracer development and distribution. Our molecular isotope research and development yield targeted agents for molecular imaging diagnosis, to help you better understand disease. To help expand the reach of molecular imaging, we simplify the complexities of radiopharmacy and radiotracer production with one complete, singletouch-point infrastructure solution that provides full end-to-end capabilities. TRACERcenter-GMP combines equipment, information, and services to help you establish and operate your own clinical research PET tracer development center or commercial diagnostic PET radiopharmacy. In addition, our robust FASTlab is an economical, flexible, automated solution to the ever-evolving challenges of tracer production. GE PET/CT imaging systems are used in targeted therapeutic drug clinical trials for early assessments of tested drugs. The foundation for many molecular imaging breakthroughs, our pre-clinical research capability promotes the development of new therapeutics and tracers by using the newest imaging technologies and disease models. Did you know? With seven or more development compounds in clinical trials at any one time, GE s portfolio of new molecular imaging agents is unrivaled.

4 Did you know? With over 80 years of experience in medical imaging technology, GE Healthcare is #1 in installed base systems in PET/CT, SPECT/CT, and cyclotrons worldwide. Care A more confident hold on patient health. If the development of new treatments can be merged with developments in diagnostics, we will have an impact on patient management, which I think is the end game here. Bengt Långström Professor Uppsala University, Sweden Imperial College, UK Odense University Hospital, Denmark GE Healthcare Molecular Imaging empowers you, as a clinician, with the tools to solve the tough clinical challenges you face daily in cardiology, neurology, and oncology disease management. The challenge is to detect small lesions to catch disease early. Stage and localize disease precisely. Accurately evaluate responses to therapy. Reduce diagnostic dilemmas to improve treatments. And make confident, well-informed clinical decisions to better manage patient care. Molecular imaging helps you do all of this. GE Healthcare Molecular Imaging offerings can help guide treatment planning of your most complex and difficult cases, while streamlining your clinical workflow. Our innovative scanner systems and relevant clinical applications in both Nuclear Medicine and PET/CT help you set yourself apart from your peers by providing remarkable advanced technology for your patients. In Nuclear Medicine, GE Healthcare s Alcyone technology reveals cardiac anatomy and pathology with greater clarity and speed, for shorter scan times and better dose management. First to market with PET/CT, GE Healthcare continues its leadership. By capturing detail and precision even in areas of the body subject to respiratory motion, our PET/CT systems give you more information to help you diagnose and stage cancer with accuracy, plan with precision, and monitor with confidence. Offering fresh vision into understanding disease, our flexible Discovery PET/CT 600 Series systems offer you the most relevant choices in advanced PET/CT capabilities and performance. Designed to excel in both clinical implementation and imaging exploration, this platform helps deliver greater precision for higher diagnostic confidence and better clinical decision making.

5 Did you know? The GE TRACERcenter-GMP is the only solution that offers all of the expertise from quality assurance and regulatory, to service support needed to implement PET imaging centers worldwide. Grow From the tiniest of molecules, huge opportunity. The increase to our department s efficiency due to the upgrade is impressive! This will give us an advantage in our market. Jim Madison Vice President HCS Group Addressing the economic aspects of healthcare in increasingly cost-conscious times can be daunting. To maximize institutional profit without compromising patient care, administrators need reliable, cost-effective equipment backed by dependable, lifelong service. GE Molecular Imaging can help you lead your facility to greater success and prestige. Your investment in understanding disease from the beginning can make as big of a difference in your bottom line as it does in your patient care. Add economic value to your department or clinic by offering specialized services that open up new opportunities in unexplored markets and clinical areas. With the reliability, upgradability, and scalability of our molecular imaging solutions, you ll be more confident in the return on your equipment investments. And your capabilities can easily grow with your changing needs. We help protect your investment through easy system upgrades without replacing equipment. We support you with ongoing software solutions, training and education, and exposure to world leaders in molecular imaging. Through GE Healthcare Financial Services, you have access to flexible, customized financing solutions that help drive affordability. The reassurance of strong after-sales service support is absolutely critical in molecular imaging and is exactly what our service offerings provide. From standard operating needs and industry requirements to asset management and new clinical informatics, we help you meet your service priorities.

6 Did you know? With the ASiR TM option on the Discovery TM NM/CT 570c and the Discovery TM PET/CT 690 systems, the CT dose to a cardiac patient can be reduced up to 44%* and with SnapShot TM Pulse up to 83%*. Prove The costs of these imaging techniques are definitely much less than the costs of surgery, particularly surgery which will be futile. Homer Macapinlac, MD Chair, Department of Nuclear Medicine The University of Texas MD Anderson Cancer Center Rising costs. Limited access. Inconsistent quality. These and other challenges make healthcare by far one of the world s most pressing and complex problems. Healthymagination is a GE business strategy designed to address these global healthcare concerns in very real and relevant ways. The goal: to provide better healthcare for more people around the world, through innovations focused on making health sustainable. To that end, GE Healthcare is committing $6 billion to launch 100+ innovations by 2015 that are proven to lower healthcare costs, increase healthcare access, and improve healthcare quality worldwide by 15%. Each innovation undergoes a rigorous process of proof and validation by an independent third-party source Oxford Analytica, an international strategic research firm specializing in monitoring and analysis. GE Healthcare Molecular Imaging products play a key role in the healthymagination initiative. With ASiR (Adaptive Statistical Iterative Reconstruction) technology, we ve implemented an improvement in hybrid system quality through the reduction of CT dose to the patient without compromising image quality. Two Molecular Imaging systems the Discovery NM/CT 570c and the Discovery PET/CT 690 have been healthymagination-validated based on ASiR technology, proof of our commitment to continually improve the quality of patient care. * The actual dose reduction level achieved will depend on the application and physician preference with specific protocols. Lead the way with GE Healthcare Molecular Imaging. Understanding disease. From the beginning.